VMP 42383911000001106

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Valsartan 160mg / Hydrochlorothiazide 12.5mg tablets
BNF code 0205052X0AAAAAA
Virtual Therapeutic Moiety Valsartan + Hydrochlorothiazide
Date identifier became valid 27 Oct 2023
Previous product identifier 395521005
Basis of preferred name Other
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Valsartan
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 160.000
Strength value numerator unit mg
Virtual Product Ingredient
Ingredient Hydrochlorothiazide
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 12.500
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Co-Diovan 160mg/12.5mg tablets (Lexon (UK) Ltd)
Co-Diovan 160mg/12.5mg tablets (Novartis Pharmaceuticals UK Ltd)
Co-Diovan 160mg/12.5mg tablets (Sigma Pharmaceuticals Plc)
Valsartan 160mg / Hydrochlorothiazide 12.5mg tablets (A A H Pharmaceuticals Ltd)
Valsartan 160mg / Hydrochlorothiazide 12.5mg tablets (Alliance Healthcare (Distribution) Ltd)
Valsartan 160mg / Hydrochlorothiazide 12.5mg tablets (Medihealth (Northern) Ltd)
Valsartan 160mg / Hydrochlorothiazide 12.5mg tablets (Sandoz Ltd)
Valsartan 160mg / Hydrochlorothiazide 12.5mg tablets (Teva UK Ltd)
Virtual Medicinal Product Packs
Valsartan 160mg / Hydrochlorothiazide 12.5mg tablets 28 tablet

dm+d data retrieved from TRUD: release NHSBSA_12.2.0_20241216000001, imported on 17th December 2024 at 04:01:15.

Feedback